PL02.01 Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
Melissa L. Johnson,
Byoung Chul Cho,
Alexander Luft,
Jorge Alatorre-Alexander,
Sarayut Lucien Geater,
Alexey E. Vasiliev,
Dmytro Trukhin,
Sujeong Kim,
G. Ursol,
Maen Hussein,
Journal of Thoracic Oncology · 2021 · 50 citations · 0 references